|Year : 2017 | Volume
| Issue : 5 | Page : 1-2
Making a prediction for something that is first of its kind
Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
|Date of Web Publication||3-Nov-2017|
Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Malhotra S. Making a prediction for something that is first of its kind. Int J Non-Commun Dis 2017;2, Suppl S1:1-2
|How to cite this URL:|
Malhotra S. Making a prediction for something that is first of its kind. Int J Non-Commun Dis [serial online] 2017 [cited 2020 Feb 19];2, Suppl S1:1-2. Available from: http://www.ijncd.org/text.asp?2017/2/5/1/217650
That hosting a World Congress of Noncommunicable Diseases (World NCD Congress) in PGIMER, Chandigarh, was an extremely ambitious project which would be quite an understatement.
From cancer to mental health, from cardiovascular to reproductive health, from oral health to stroke, from respiratory and kidney disorders to bone disease, from drug addiction to medication adherence, from nutrition to injuries, and from epidemiological research to clinical trials - was there anything that was out of the scope of this event? Infectious diseases, you may argue, as did one of the luminaries who we had gone to invite for the Congress. But, when informed that a patient with a NCD like diabetes is not only more prone to infections, but also if infection does occur, his outcomes are poorer. This would give you an idea about the scope of this Congress.
Therefore, it is not surprising that when the planning for the Congress started, many of us were rationally skeptical. Well, nothing of similar proportions had ever been done in our Institute, perhaps even nationally, or even worldwide. And, we were trying to hold it in Chandigarh city, not even in Delhi or other metro city. One person who never doubted was Arun Chockalingam, ev]en when, with just a few weeks to go, the number of abstracts received remained in two figures.
For a newly formed organization, the World NCD Federation, this was not even equivalent to baby steps - it was more like the weird sounds produced by a neonate, perhaps showing her happiness to become a part of this world. Like a parent encouraging even ordinary acts of his child, even when the child is too young to even understand, Arun would support, guide, and encourage us, always maintaining optimism, never showing worry, although we could sometimes sense that he was concerned.
In the end, to our pleasant surprise, our doomsday predictions would turn out to be plain wrong (there was no model on which to base these predictions), and Arun's confidence in us justified - we received nearly 500 abstracts, which were categorized into several themes and subthemes, of which around 20% were selected for oral presentations, the rest were approved as posters with our reviewers also rejecting a few [Table 1].
|Table 1: Theme-wise distribution of abstracts selected for the World Noncommunicable Diseases Congress 2017|
Click here to view
Even more satisfying was the participation of delegates from more than twenty countries [Table 2]. Untiring efforts of Dr. JS Thakur and Dr. R. Kapoor and the other members, along with Dr. DN Sinha, resulted in such response. The contribution of the research fellows, students, and residents, who doubled and trebled on their duties, cannot be ignored. Even the patients contributed by patiently waiting, while some of their doctors were busy planning this Congress, on the rare occasions when we could not hold our meetings in the evening. Finally, the abstract reviewers deserve a big applause for providing their critical inputs, suggesting changes, which went a long way in improving the quality of the abstracts. My apologies to those who might have been left out inadvertently.
|Table 2: Number of countries from where abstracts have been received for World Noncommunicable Diseases Congress 2017|
Click here to view
I will like to end with Hope, incidentally the acronym for landmark trials in cardiovascular medicine. Hope-1 would be that the Congress does achieve its objectives, which we will know soon, and Hope-2 that the next one is better - the alert reader would note that I have not used the word "bigger."
I would like to thank Dr. Harman Siddu, for painstakingly classifying abstracts into categories and subcategories, corresponding with the reviewers and helping prepare this editorial.
[Table 1], [Table 2]